Casebia Therapeutics
An innovative gene editing company discovering and developing curative treatments for genetic diseases
1 employees · est. 2016 · Cambridge, United States
CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
350 employees · est. 2013 · Boston, United States
CRISPR Therapeutics is the older company (2016 vs 2013); CRISPR Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Casebia Therapeutics | CRISPR Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2013 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Boston, United States |
| Employees | ||
| Employees | 1 | 350 larger |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Not tracked yet | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $1.05B |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 7 |
| Services | ||
| Services | Not tracked yet | Development of gene-based medicines, Gene-editing therapies, Clinical and preclinical research, Patient advocacy |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with serious diseases, Healthcare providers, Biotechnology companies, Research institutions |
| Taxonomy | ||
| Taxonomy | Gene Editing, Therapeutics, Medical Innovation, CRISPR-Cas9, Protein Engineering, Targeted Delivery, Hematology, Ophthalmology, Rare Diseases | Gene-based Medicines, CRISPR Technology, Gene Editing, Hematology, Oncology, Regenerative Medicine, Cardiovascular Diseases, Autoimmune Diseases, Rare Diseases, Transfusion-Dependent Beta Thalassemia, Sickle Cell Disease, Biopharmaceuticals, CRISPR/Cas9 Platform, Strategic Partnerships, Nobel Prize-winning Innovations |
| Website | ||
| Website | casebia.com | crisprtx.com |
About Casebia Therapeutics
Casebia Therapeutics is a biotechnology startup based in the United States, founded in 2016. Positioning itself as an innovative gene editing company, it is dedicated to discovering and developing curative treatments for genetic diseases. Through a strategic partnership between Bayer and CRISPR Ther...
About CRISPR Therapeutics
CRISPR Therapeutics, a leader in biopharma and biotechnology, stands at the forefront of creating gene-based medicines for patients with serious diseases. Since its founding in 2013, the company has not only evolved but thrived by leveraging CRISPR technology, a Nobel Prize-winning innovation that h...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Casebia Therapeutics and CRISPR Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Casebia Therapeutics or CRISPR Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Casebia Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Casebia Therapeutics on 14 Sep 2024, and CRISPR Therapeutics on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
